Is Translational Research In Oncology Us Inc Legit?
Quick charity verification for Translational Research In Oncology Us Inc (EIN: 200132719)
Verdict: Translational Research In Oncology Us Inc appears trustworthy
95/100Mission Score
$15.7MRevenue
$25.8MAssets
1Red Flags
3Strengths
Red Flags
Consistent 0% officer compensation for an organization of this size, which may obscure actual leadership compensation if paid by an affiliate.
Strengths
Strong and consistent asset growth, from $7.8 million in 2011 to $24.5 million in 2023.
High apparent program efficiency due to reported 0% officer compensation, suggesting funds are directed to mission.
Stable financial operations with consistent revenue generation over more than a decade.
Spending Breakdown
How Translational Research In Oncology Us Inc allocates its funds across programs, administration, and fundraising.
100%
Program Spending
Healthy — majority goes to mission
0%
Admin Costs
Reasonable — admin costs in check
0%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about Translational Research In Oncology Us Inc
Is Translational Research In Oncology Us Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Translational Research In Oncology Us Inc (EIN: 200132719) appears trustworthy. Mission Score: 95/100. 1 red flag identified, 3 strengths noted.
Is Translational Research In Oncology Us Inc a good charity to donate to?
Translational Research In Oncology Us Inc has a Mission Score of 95/100. Revenue: $15.7M. Assets: $25.8M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for Translational Research In Oncology Us Inc?
The Employer Identification Number (EIN) for Translational Research In Oncology Us Inc is 200132719. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does Translational Research In Oncology Us Inc spend its money?
Translational Research In Oncology Us Inc allocates 100% to programs, 0% to administration, and 0% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify Translational Research In Oncology Us Inc's tax-exempt status?
You can verify Translational Research In Oncology Us Inc's tax-exempt status using EIN 200132719 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
Translational Research In Oncology Us Inc demonstrates consistent financial health with a strong asset base and generally stable revenue streams. The organization has shown steady growth in assets, from $7.8 million in 2011 to $24.5 million in 2023, indicating effective financial management and accumulation of resources. Their spending efficiency appears robust, as evidenced by their program spending ratio, which is typically very high. For instance, in 2023, with expenses of $8,516,990 and no reported officer compensation, it suggests a significant portion of funds are directed towards their mission. The consistent reporting of zero officer compensation across all available filings is a notable indicator of transparency and a commitment to directing funds to programmatic activities rather than executive salaries. This practice, while unusual, suggests a highly volunteer-driven or externally compensated leadership structure, which merits further investigation for complete transparency.